Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety study of two herbal ointments for ringworm
PACTR202506482015278Phase 1Not yet recruiting
- Sponsor
- Armauer Hansen Research Institute
- Start
- Jun 2025
- Countries
- 1
01
Overview
Phase 1, open-label trial of vehicle in tinea corporis (3 arms), sponsored by Armauer Hansen Research Institute. Primary endpoint: Occurrence of serious adverse drug reactions. Planned start Jun 2025; status: not yet recruiting.
02
Drugs
vehicle
03
Conditions
tinea corporis
Beyond the preview
Go deeper on PACTR202506482015278.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202506482015278.